We are live on
!
Find out more
TE
Tema ETFs Portfolio holdings
AUM
$3.09B
1-Year Est. Return
72.72%
This Fund
S&P 500
This Quarter
Est. Return
-1.1%
1 Year Est. Return
+72.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$241M
AUM Growth
–
Cap. Flow
+$255M
Cap. Flow
% of AUM
105.95%
Top 10 Holdings %
Top 10 Hldgs %
27.78%
Holding
148
New
148
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rockwell Automation
ROK
|
+$8.98M |
| 2 |
Applied Industrial Technologies
AIT
|
+$8.46M |
| 3 |
Clean Harbors
CLH
|
+$7.13M |
| 4 |
Timken Company
TKR
|
+$6.85M |
| 5 |
Primoris Services
PRIM
|
+$6.82M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 46.25% |
| 2 | Healthcare | 42.59% |
| 3 | Technology | 3.29% |
| 4 | Materials | 2.86% |
| 5 | Financials | 2.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Crinetics Pharmaceuticals
CRNX
$8.88B
| $2.96M | 1.23% |
+57,933
| New | +$3.24M |
|
27
Amgen
AMGN
$198B
| $2.91M | 1.21% |
+11,179
| New | +$3.32M |
|
28
Gilead Sciences
GILD
$167B
| $2.85M | 1.18% |
+30,846
| New | +$2.78M |
|
29
Terex
TEX
$7.47B
| $2.84M | 1.18% |
+61,544
| New | +$3.21M |
|
30
argenx
ARGX
$53.8B
| $2.83M | 1.17% |
+4,598
| New | +$2.69M |
|
31
Ascendis Pharma A/S
ASND
$17.1B
| $2.62M | 1.09% |
+19,040
| New | +$2.5M |
|
32
TSMC
TSM
$2.07T
| $2.25M | 0.93% |
+11,368
| New | +$2.2M |
|
33
Cytokinetics
CYTK
$10.9B
| $2.23M | 0.93% |
+47,383
| New | +$2.46M |
|
34
DexCom
DXCM
$29.6B
| $2.23M | 0.92% |
+28,643
| New | +$2.12M |
|
35
Incyte
INCY
$23.4B
| $2.1M | 0.87% |
+30,378
| New | +$2.16M |
|
36
Revolution Medicines
RVMD
$39.6B
| $1.99M | 0.83% |
+45,522
| New | +$2.3M |
|
37
Ionis Pharmaceuticals
IONS
$8.99B
| $1.99M | 0.83% |
+56,844
| New | +$2.12M |
|
|
BPMC
38
DELISTED
Blueprint Medicines
BPMC
| $1.96M | 0.81% |
+22,474
| New | +$2.06M |
|
39
Illumina
ILMN
$28.2B
| $1.9M | 0.79% |
+14,239
| New | +$2.03M |
|
40
Boston Scientific
BSX
$65.4B
| $1.83M | 0.76% |
+20,494
| New | +$1.8M |
|
41
Mirum Pharmaceuticals
MIRM
$7.25B
| $1.74M | 0.72% |
+41,968
| New | +$1.75M |
|
42
Intellia Therapeutics
NTLA
$1.59B
| $1.73M | 0.72% |
+148,167
| New | +$2.31M |
|
43
Union Pacific
UNP
$179B
| $1.69M | 0.7% |
+7,413
| New | +$1.75M |
|
44
Exelixis
EXEL
$14.1B
| $1.64M | 0.68% |
+49,256
| New | +$1.6M |
|
45
Edwards Lifesciences
EW
$49.4B
| $1.6M | 0.67% |
+21,635
| New | +$1.51M |
|
|
MASI
46
DELISTED
Masimo
MASI
| $1.58M | 0.66% |
+9,580
| New | +$1.51M |
|
47
Danaher
DHR
$144B
| $1.58M | 0.65% |
+6,869
| New | +$1.69M |
|
48
Insulet
PODD
$11.4B
| $1.41M | 0.58% |
+5,385
| New | +$1.36M |
|
49
Thermo Fisher Scientific
TMO
$198B
| $1.32M | 0.55% |
+2,534
| New | +$1.39M |
|
50
Moody's
MCO
$89.2B
| $1.24M | 0.51% |
+2,611
| New | +$1.25M |
|
Similar funds
DCM
HCM
KF
TCG
PC
CAM
VBA
FI
Tema ETFs's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Tema ETFs, which disclosed 148 positions worth $241M. Its ten largest holdings account for 28% of the portfolio.
Its largest position is Rockwell Automation: 31,912 shares worth $9.12M.
By sector, the portfolio is most concentrated in Industrials at 46% of assets, followed by Healthcare and Technology.
- Tema ETFs's largest Q4 2024 buy was Rockwell Automation: 31,912 shares worth $9.12M.
- Tema ETFs's ten largest holdings make up 28% of its $241M portfolio in Q4 2024.
- Tema ETFs disclosed 148 positions in Q4 2024, its first 13F filing on record.
Based on Tema ETFs's 13F filing for Q4 2024, filed 14 Feb 2025.